Dr. Anil Perumbeti, MD

Dr. Perumbeti practices at Eisenhower Health in Rancho Mirage, California, part of Eisenhower Medical Center.

Dr. Perumbeti's NPI, 1043522956, was assigned on July 8, 2010. Dr. Perumbeti graduated from Northeast Ohio Medical University in 2008. Dr. Perumbeti's California license number on file is A113144.

Dr. Perumbeti's primary practice is Eisenhower Health, at 39-000 Bob Hope Drive, Rancho Mirage, CA 92270 in Riverside County. The practice phone is (760) 340-3911. Dr. Perumbeti also practices at Eisenhower Medical Center, 39000 Bob Hope Dr, Rancho Mirage, CA 92270.

Dr. Perumbeti's primary practice is Eisenhower Health in Rancho Mirage, California, part of Eisenhower Medical Center. Dr. Perumbeti is also affiliated with Desert Regional Medical Center. The medical group on file is Eisenhower Health. Dmand AI also links Dr. Perumbeti to 1 more breast imaging center, 1 clinical lab, 1 dialysis center and 1 home health agency, each named with a free account. Dr. Perumbeti's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Perumbeti practices, 6 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Perumbeti's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Perumbeti is board certified in critical care medicine by the American Board of Internal Medicine. Dr. Perumbeti has a license on file in California.

Dmand AI lists asthma, bronchitis, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, chronic sinusitis, pleural effusion and pneumonia among the conditions Dr. Perumbeti treats.

CMS data shows 2,017 Medicare services from Dr. Perumbeti across 20 procedure codes in 2024, for 914 Medicare patients. Medicare paid $168,532 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 914 Medicare patients who saw Dr. Perumbeti in 2024. The largest group is 75 to 84, with 422 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Perumbeti's median patient age at 78, with 50% women.

In 2024, Dr. Perumbeti wrote 1,804 Medicare Part D claims for 412 patients. CMS names the drug for 1,624 of them, across 27 drugs with 11 or more claims each, at $1,482,208 in total drug cost. In 2023, CMS named 1,674 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Perumbeti for performance year 2024, reported as part of a group. Dr. Perumbeti accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Perumbeti as offering telehealth.

Dmand AI links 2 papers to Dr. Perumbeti, published from 2022 to 2024. Dr. Perumbeti's most frequent co-authors are Betul Nurefsan Bayraktutar, MD, Kevin Chan and Adam Farzaneh, MD.

CMS Open Payments shows 42 general payments to Dr. Perumbeti from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. GlaxoSmithKline, LLC. paid the most, $246.

Dr. Perumbeti graduated from Northeast Ohio Medical University in 2008.

Dr. Perumbeti is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.